NEXGEL (NXGL) Competitors $3.37 -0.13 (-3.71%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NXGL vs. FONR, GUTS, LNSR, MLSS, MGRM, EDAP, HYPR, VANI, STIM, and NSPRShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include FONAR (FONR), Fractyl Health (GUTS), LENSAR (LNSR), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), Hyperfine (HYPR), Vivani Medical (VANI), Neuronetics (STIM), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry. NEXGEL vs. FONAR Fractyl Health LENSAR Milestone Scientific Monogram Orthopaedics Edap Tms Hyperfine Vivani Medical Neuronetics InspireMD FONAR (NASDAQ:FONR) and NEXGEL (NASDAQ:NXGL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, community ranking, dividends and earnings. Is FONR or NXGL more profitable? FONAR has a net margin of 9.41% compared to NEXGEL's net margin of -52.60%. FONAR's return on equity of 6.10% beat NEXGEL's return on equity.Company Net Margins Return on Equity Return on Assets FONAR9.41% 6.10% 4.58% NEXGEL -52.60%-71.19%-34.79% Do institutionals and insiders have more ownership in FONR or NXGL? 50.6% of FONAR shares are held by institutional investors. Comparatively, 2.2% of NEXGEL shares are held by institutional investors. 2.2% of FONAR shares are held by insiders. Comparatively, 24.9% of NEXGEL shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, FONR or NXGL? FONAR has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Does the MarketBeat Community prefer FONR or NXGL? FONAR received 179 more outperform votes than NEXGEL when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 50.00% of users gave NEXGEL an outperform vote. CompanyUnderperformOutperformFONAROutperform Votes18074.69% Underperform Votes6125.31% NEXGELOutperform Votes150.00% Underperform Votes150.00% Which has better earnings and valuation, FONR or NXGL? FONAR has higher revenue and earnings than NEXGEL. NEXGEL is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFONAR$102.88M0.94$10.57M$1.4010.86NEXGEL$4.09M5.59-$3.16M-$0.58-5.81 Does the media refer more to FONR or NXGL? In the previous week, FONAR had 2 more articles in the media than NEXGEL. MarketBeat recorded 2 mentions for FONAR and 0 mentions for NEXGEL. FONAR's average media sentiment score of 0.47 beat NEXGEL's score of 0.00 indicating that FONAR is being referred to more favorably in the media. Company Overall Sentiment FONAR Neutral NEXGEL Neutral SummaryFONAR beats NEXGEL on 13 of the 15 factors compared between the two stocks. Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNEXGELSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.88M$4.83B$5.39B$9.13BDividend YieldN/A52.58%5.37%4.00%P/E Ratio-5.8126.8888.8317.53Price / Sales5.5957.951,282.2680.28Price / CashN/A50.8936.6032.90Price / Book3.747.904.964.69Net Income-$3.16M$13.87M$117.89M$224.57M7 Day Performance-2.32%4.15%2.75%3.33%1 Month Performance-28.75%11.37%3.63%5.33%1 Year Performance40.90%33.39%27.27%22.97% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNEXGEL0.4168 of 5 stars$3.37-3.7%N/A+46.3%$22.88M$4.09M-5.8110FONRFONAR1.3077 of 5 stars$15.13-0.7%N/A-20.2%$95.74M$102.01M10.81480Short Interest ↑GUTSFractyl Health1.6781 of 5 stars$1.95+5.4%$22.00+1,028.2%N/A$93.79M$97,000.00-0.16102Positive NewsGap UpHigh Trading VolumeLNSRLENSAR0.8371 of 5 stars$8.06-2.3%$8.00-0.7%+133.1%$93.62M$48.87M-5.52110Positive NewsMLSSMilestone Scientific0.3741 of 5 stars$1.08-8.5%$1.25+15.7%+96.7%$84.12M$8.88M-15.4330Analyst ForecastNews CoverageMGRMMonogram Orthopaedics3.5095 of 5 stars$2.45-2.0%$4.00+63.3%-19.2%$84.06M$364,999.00-5.2128EDAPEdap Tms3.4692 of 5 stars$2.07-1.4%$19.00+817.9%-64.5%$76.81M$63.41M-3.18307HYPRHyperfine1.9896 of 5 stars$0.98+4.3%$1.60+63.3%+2.0%$71.49M$13.26M-1.72190VANIVivani Medical3.5766 of 5 stars$1.20-0.8%$3.00+150.0%+17.6%$71.08MN/A-2.6720Positive NewsSTIMNeuronetics3.1859 of 5 stars$2.34+36.8%$4.67+99.4%-25.9%$71.01M$72.71M-1.90180News CoveragePositive NewsHigh Trading VolumeNSPRInspireMD2.5526 of 5 stars$2.65-4.0%$4.75+79.2%-12.3%$69.12M$6.82M-3.5350Analyst ForecastNews Coverage Related Companies and Tools Related Companies FONR Alternatives GUTS Alternatives LNSR Alternatives MLSS Alternatives MGRM Alternatives EDAP Alternatives HYPR Alternatives VANI Alternatives STIM Alternatives NSPR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NXGL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXGL Stock Alerts